reversal pathological pain specific spinal gabaa receptor subtypes 
inflammatory diseases neuropathic insults frequently accompanied severe debilitating pain can become chronic often unresponsive conventional analgesic treatment loss synaptic inhibition spinal dorsal horn considered contribute significantly pain pathology- facilitation spinal gamma-aminobutyric acid gaba ergic neurotransmission modulation gabaa receptors able compensate loss use gabaa-receptor point mutated knock mice specific gabaa receptor subtypes selectively rendered insensitive benzodiazepine site ligands- show pronounced analgesia can achieved specifically targeting spinal gabaa receptors containing alpha and/ alpha subunits show selective activation non sedative alpha sparing benzodiazepine site ligand l ref highly effective inflammatory neuropathic pain yet devoid unwanted sedation motor impairment tolerance development l diminished nociceptive input brain also reduced activity brain areas related associative emotional components pain shown functional magnetic resonance imaging rats results provide rational basis development subtype selective gabaergic drugs treatment chronic pain often refractory classical analgesics 
